High expression of ACE2 and TMPRSS2 in the small intestines may support gastrointestinal-correlated replication of SARS-COV-2, according to a study published in Gastroenterology.

“We investigated two aspects of COVID-19 biology and describe one of the most detailed protein and gene expression characterizations of COVID-19 receptors in the intestinal tract to date,” Saurabh Mehandru, MD, principal investigator, and associate professor of gastroenterology, Icahn School of Medicine at Mount Sinai, said in a Mount Sinai press release. “We have found that the SARS-CoV-2 receptor,

Full Article: https://www.healio.com/news/gastroenterology/20200925/small-intestine-cells-at-risk-for-covid19-infection-in-ibd-patients